Amelia A. Langston, MD

One star
One star
One star
One star
One star

Rating: 5 out of 5 (290 ratings)

Role

Hematology Oncology
Specialty

Leukemia Lymphoma Myeloma and Plasma Cell Disorders Myelodysplastic Syndromes
Research Program

Discovery and Developmental Therapeutics
Practicing Since

1990

Call 404-778-0519

Background

Board certified in internal medicine, hematology and medical oncology, Amelia A. Langston, MD, treats patients with leukemia, myelodysplastic syndrome, lymphoma, graft-versus-host disease (GVHD), aplastic anemia and HIV-related malignancies. Dr. Langston is a practicing physician with Emory Healthcare since 1998.

Titles & Roles

Winship 5K Research Professor and Executive Vice Chair, Department of Hematology and Medical Oncology

Emory University School of Medicine
Director, Bone Marrow and Stem Cell Transplant Program

Winship Cancer Institute of Emory University
Medical Director, Winship Cancer Network

Winship Cancer Institute of Emory University
Executive Vice Chair, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Medical Oncology, 1990
Univ of WA Medical Center
Residency, Internal Medicine, 1987
Duke University Medical Center
Internship, Internal Medicine, 1985
Duke University Medical Center
Medical Education, MD, 1984
Washington University School of Medicine

Board Certifications

Medical Oncology
American Board of Internal Medicine, 1989
Internal Medicine
American Board of Internal Medicine, 1987

Professional Memberships

American Association for the Advancement of Science
American Society of Hematology

Research

Dr. Langston's research interests include novel strategies for autologous and allogeneic stem cell transplantation, use of biologically targeted agents for antileukemic therapy, and prevention and treatment of opportunistic infections in immunocompromised patients.

View Current Clinical Trials


DALY II USA/ MB-CART2019.1 for DLBCL Phase II Conditions Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL), Primary Mediastinal B-cell Lymphoma (PMBCL), Transformed Lymphoma, Central Nervous System Lymphoma, Mantle Cell Lymphoma (MCL), Richter Transformation, Transplant-ineligible 2nd Line DLBCL Location Winship Cancer Institute
Managed Access Programs for CTL019, Tisagenlecleucel Phase Expanded Access Conditions Lymphoma, Leukemia, Off-label Indications Location Winship Cancer Institute
MAGIC Ruxolitinib for aGVHD Phase II Conditions Acute Graft-versus-host Disease, Allogeneic Bone Marrow Transplantation, Adverse Effects Location Winship Cancer Institute
Ivosidenib as Post-HSCT Maintenance for AML Phase II Conditions IDH1 Mutation, Acute Myeloid Leukemia (AML), Hematopoietic Stem Cell Transplant (HSCT) Location Winship Cancer Institute
Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release Phase Expanded Access Conditions Unresectable Melanoma, Metastatic Melanoma Location Winship Cancer Institute
Expanded Access Program for OOS Obe-cel Phase Expanded Access Conditions Lymphoblastic Leukemia, Acute, Adult, B Cell ALL Location Winship Cancer Institute

Publications

Title/Journal	Authors	Publication Date
Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results. Research square	N Shah, H Choe, N Hardy, P Chevallier, MT Rubio, M Schroeder, C Solano, A Langston, P Stiff, K Hou, M Arbushites, M Pratta, R Morariu-Zamfir, MA Perales	06/11/2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents. American journal of hematology	S Fathima, MM Wong, J Gonzalez-Lugo, SM Geyer, A Alsugair, M Sirenko, KJ Langer, TL Lasho, C Finke, J Choi, M Abdul-Hay, G Ho, MR Litzow, A Matin, U Durani, M Hefazi, WJ Hogan, MV Shah, A Al-Kali, KH Begna, N Gangat, AN Saliba, RS Go, T Kewan, G Bartoo, J Kutzke, K McCullough, KJ Warrington, M Sullivan, KK Reichard, H Olteanu, H Murthy, T Badar, Y Kusne, J Palmer, S Chhabra, N Punwani, M Riwes, JP McGuirk, EF Krakow, A Langston, T Kourelis, D Dingli, J Foran, MJ Koster, MM Patnaik, DB Beck, HB Alkhateeb, AA Mangaonkar	06/08/2026
Hodgkin Lymphoma Treatment With Brentuximab Vedotin in a Patient With HIV, Liver Failure, and Anemia Without Transfusion. EJHaem	E Marin, A Abousaud, K Davis, B Sumrall, S Li, AA Langston, A Chang	02/01/2025
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities. Transplantation and cellular therapy	T Takahashi, B Watkins, B Bratrude, D Neuberg, K Hebert, K Betz, A Yu, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, A Langston, LS Kean, M Qayed	02/01/2025
(Donor) age is more than just a number…. Bone marrow transplantation	C Vale, AA Langston	01/01/2025
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation. Blood	LS Kean, LJ Burns, TD Kou, R Kapikian, K Lozenski, A Langston, JT Horan, B Watkins, M Qayed, B Bratrude, K Betz, XY Tang, MJ Zhang, SE Connolly, M Polinsky, B Gavin, A Gomez-Caminero, MC Pasquini	10/24/2024
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G-CSF and Plerixafor: A single center project. Journal of clinical apheresis	A Javanbakht, S Stringer, H Anderson, E Hamilton, A Philip, EK Waller, AA Langston, N Joseph, JD Roback, T Schneider, HC Sullivan, JE Hendrickson	06/01/2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD. Bone marrow transplantation	L Gorfinkel, S Raghunandan, B Watkins, K Hebert, DS Neuberg, B Bratrude, K Betz, A Yu, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, A Langston, LS Kean, M Qayed	05/01/2024
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies. Bone marrow transplantation	S Raghunandan, M Qayed, BK Watkins, M Graiser, L Gorfinkel, A Westbrook, S Gillespie, B Bratrude, A Petrovic, Y Suessmuth, J Horan, LS Kean, AA Langston	11/01/2023
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis. Bone marrow transplantation	S Raghunandan, L Gorfinkel, B Bratrude, Y Suessmuth, K Hebert, D Neuberg, KM Williams, ML Schoettler, AA Langston, LS Kean, M Qayed, J Horan, BK Watkins	11/01/2023
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Blood advances	MM Al Malki, K London, J Baez, Y Akahoshi, WJ Hogan, A Etra, H Choe, E Hexner, A Langston, S Abhyankar, DM Ponce, Z DeFilipp, CL Kitko, K Adekola, R Reshef, F Ayuk, A Capellini, C Chanswangphuwana, M Eder, G Eng, I Gandhi, S Grupp, S Gleich, E Holler, NR Javorniczky, S Kasikis, S Kowalyk, G Morales, U Özbek, W Rösler, N Spyrou, G Yanik, R Young, YB Chen, R Nakamura, JLM Ferrara, JE Levine	09/12/2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events. Blood	T Takahashi, M Al-Kofahi, M Jaber, B Bratrude, K Betz, Y Suessmuth, A Yu, DS Neuberg, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, B Watkins, A Langston, M Qayed, LS Kean	08/24/2023
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis. Blood advances	S Raghunandan, L Gorfinkel, M Graiser, B Bratrude, Y Suessmuth, S Gillespie, AL Westbrook, KM Williams, ML Schoettler, LS Kean, J Horan, AA Langston, M Qayed, B Watkins	08/22/2023
Passenger pathogens on physicians. American journal of infection control	CR Funk, S Ravindranathan, A Matelski, H Zhang, C Taylor, S Chandrasekaran, M Arellano, AA Langston, N Joseph, EK Waller	07/01/2023
Effective treatment of low-risk acute GVHD with itacitinib monotherapy. Blood	A Etra, A Capellini, A Alousi, MM Al Malki, H Choe, Z DeFilipp, WJ Hogan, CL Kitko, F Ayuk, J Baez, I Gandhi, S Kasikis, S Gleich, E Hexner, M Hoepting, U Kapoor, S Kowalyk, D Kwon, A Langston, M Mielcarek, G Morales, U Özbek, M Qayed, R Reshef, W Rösler, N Spyrou, R Young, YB Chen, JLM Ferrara, JE Levine	02/02/2023
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation. Blood advances	M Qayed, B Watkins, S Gillespie, B Bratrude, K Betz, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, M Norkin, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, EK Waller, A Langston, LS Kean, JT Horan	02/08/2022
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease. Frontiers in immunology	E Stenger, CR Giver, A Langston, D Kota, PK Das, R Chinnadurai, J Galipeau, EK Waller, M Qayed	01/01/2022
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood	C Cutler, SJ Lee, S Arai, M Rotta, B Zoghi, A Lazaryan, A Ramakrishnan, Z DeFilipp, A Salhotra, W Chai-Ho, R Mehta, T Wang, M Arora, I Pusic, A Saad, NN Shah, S Abhyankar, C Bachier, J Galvin, A Im, A Langston, J Liesveld, M Juckett, A Logan, L Schachter, A Alavi, D Howard, HW Waksal, J Ryan, D Eiznhamer, SK Aggarwal, J Ieyoub, O Schueller, L Green, Z Yang, H Krenz, M Jagasia, BR Blazar, S Pavletic	12/02/2021
Cytomegalovirus immunoglobulin G: passive transfer or prior infection? British journal of haematology	M Byrne, AA Langston, GS Booth	10/01/2021
A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies. Transplantation and cellular therapy	W Saber, P Steinert, MJ Zhang, M Chen, A Pope, A Keating, JR Wingard, K Ballen, P Stiff, MA Perales, S Forman, R Champlin, A Langston, M Rudebeck, M Horowitz	10/01/2021
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome. Blood advances	AF Herrera, KW Ahn, C Litovich, Y Chen, A Assal, Q Bashir, RL Bayer, M Coleman, Z DeFilipp, N Farhadfar, M Greenwood, T Hahn, M Horwitz, C Jacobson, S Jaglowski, S Lachance, A Langston, B Mattar, RT Maziarz, J McGuirk, MAH Mian, S Nathan, A Phillips, K Rakszawski, H Sengeloev, S Shenoy, R Stuart, CS Sauter, MA Kharfan-Dabaja, M Hamadani	09/28/2021
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	B Watkins, M Qayed, C McCracken, B Bratrude, K Betz, Y Suessmuth, A Yu, S Sinclair, S Furlan, S Bosinger, V Tkachev, J Rhodes, AG Tumlin, A Narayan, K Cribbin, S Gillespie, TA Gooley, MC Pasquini, K Hebert, U Kapoor, A Rogatko, M Tighiouart, S Kim, C Bresee, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, M Norkin, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, EK Waller, JE Levine, JL Ferrara, BR Blazar, A Langston, JT Horan, LS Kean	06/10/2021
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades. Haematologica	JP Cooper, BE Storer, N Granot, B Gyurkocza, ML Sorror, TR Chauncey, J Shizuru, GN Franke, MB Maris, M Boyer, B Bruno, F Sahebi, AA Langston, P Hari, ED Agura, S Lykke Petersen, RT Maziarz, W Bethge, J Asch, JA Gutman, G Olesen, AM Yeager, K Hübel, WJ Hogan, DG Maloney, M Mielcarek, PJ Martin, MED Flowers, GE Georges, AE Woolfrey, JH Deeg, BL Scott, GB McDonald, R Storb, BM Sandmaier	06/01/2021
Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation. British journal of haematology	GS Booth, BN Savani, AA Langston	05/01/2021
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia. JCO oncology practice	AP Jillella, ML Arellano, M Gaddh, AA Langston, LT Heffner, EF Winton, ML McLemore, C Zhang, CR Caprara, KS Simon, SL Bolds, S DeBragga, P Karkhanis, SH Krishnamurthy, J Tongol, MM El Geneidy, A Pati, JM Gerber, MR Grunwald, J Cortes, A Bashey, RK Stuart, VK Kota	04/01/2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients. EClinicalMedicine	P Ljungman, A Bermudez, AC Logan, MA Kharfan-Dabaja, P Chevallier, R Martino, G Wulf, D Selleslag, K Kakihana, A Langston, DG Lee, C Solano, S Okamoto, LR Smith, M Boeckh, JR Wingard, B Cywin, C Fredericks, C Lademacher, X Wang, J Young, J Maertens	03/01/2021
Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection. Open forum infectious diseases	AC Sherman, X Lu, E Schneider, A Langston, CL Ellis, S Pastan, J Bhatnagar, S Reagan-Steiner, P Annambhotla, S Lindstrom, A Mehta, SM Pouch, ME Sexton	03/01/2021
Why does the place where the allogeneic transplant patient calls home matter? Cancer	AA Langston	02/15/2021
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8⁺ T cells drive gastrointestinal acute graft-versus-host disease. Science translational medicine	V Tkachev, J Kaminski, EL Potter, SN Furlan, A Yu, DJ Hunt, C McGuckin, H Zheng, L Colonna, U Gerdemann, J Carlson, M Hoffman, J Olvera, C English, A Baldessari, A Panoskaltsis-Mortari, B Watkins, M Qayed, Y Suessmuth, K Betz, B Bratrude, A Langston, JT Horan, J Ordovas-Montanes, AK Shalek, BR Blazar, M Roederer, LS Kean	01/13/2021
Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer. The oncologist	AA Langston, TE Quest, ER Abernethy, GP Campbell, TK Owonikoko, RD Pentz	10/01/2020
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study. Cancer	JB Cohen, L Wei, KJ Maddocks, B Christian, LT Heffner, AA Langston, MJ Lechowicz, P Porcu, CR Flowers, SM Devine, KA Blum	03/15/2020
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience. Bone marrow transplantation	M Shadman, DG Maloney, B Storer, BM Sandmaier, TR Chauncey, N Smedegaard Andersen, D Niederwieser, J Shizuru, B Bruno, MA Pulsipher, RT Maziarz, ED Agura, P Hari, AA Langston, MB Maris, PA McSweeney, R Storb, ML Sorror	01/01/2020
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report. Clinical cancer research : an official journal of the American Association for Cancer Research	HT Kim, KW Ahn, ZH Hu, MS Davids, VO Volpe, JH Antin, ML Sorror, M Shadman, O Press, J Pidala, W Hogan, R Negrin, S Devine, J Uberti, E Agura, R Nash, J Mehta, J McGuirk, S Forman, A Langston, SA Giralt, MA Perales, M Battiwalla, GA Hale, RP Gale, DI Marks, M Hamadani, S Ganguly, U Bacher, H Lazarus, R Reshef, GC Hildebrandt, Y Inamoto, JY Cahn, M Solh, MA Kharfan-Dabaja, N Ghosh, A Saad, M Aljurf, HC Schouten, BT Hill, A Pawarode, T Kindwall-Keller, N Saba, EA Copelan, S Nathan, A Beitinjaneh, BN Savani, J Cerny, MR Grunwald, J Yared, BM Wirk, T Nishihori, S Chhabra, RF Olsson, A Bashey, U Gergis, U Popat, R Sobecks, E Alyea, W Saber, JR Brown	08/15/2019
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. The Lancet. Haematology	BM Sandmaier, B Kornblit, BE Storer, G Olesen, MB Maris, AA Langston, JA Gutman, SL Petersen, TR Chauncey, WA Bethge, MA Pulsipher, AE Woolfrey, M Mielcarek, PJ Martin, FR Appelbaum, MED Flowers, DG Maloney, R Storb	08/01/2019
Acute Myeloid Leukemia in Young Adults: Does Everyone Need a Transplant? Journal of oncology practice	D Roberts MMSc, AA Langston, LT Heffner	06/01/2019
Follow-up to comment on "Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta-Analysis". Journal of thrombosis and haemostasis : JTH	MAT Elsebaie, N Van Es, A Langston, HR Büller, M Gaddh	06/01/2019
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America	GA Papanicolaou, FP Silveira, AA Langston, MR Pereira, RK Avery, M Uknis, A Wijatyk, J Wu, M Boeckh, FM Marty, S Villano	04/08/2019
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH	MAT Elsebaie, N van Es, A Langston, HR Büller, M Gaddh	04/01/2019
Safety and survival outcomes for bloodless transplantation in patients with myeloma. Cancer	NS Joseph, JL Kaufman, LH Boise, K Valla, DK Almaula, CO Obidike, AA Langston, EK Waller, HJ Khoury, CR Flowers, M Graiser, LT Heffner, S Lonial, AK Nooka	01/15/2019
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report. International journal of molecular sciences	CR Funk, CT Petersen, N Jagirdar, S Ravindranathan, DL Jaye, CR Flowers, A Langston, EK Waller	12/19/2018
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	RA Taplitz, EB Kennedy, EJ Bow, J Crews, C Gleason, DK Hawley, AA Langston, LJ Nastoupil, M Rajotte, KV Rolston, L Strasfeld, CR Flowers	10/20/2018
Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease. Bone marrow transplantation	HJ Khoury, AA Langston, VK Kota, JA Wilkinson, I Pusic, A Jillella, S Bauer, AS Kim, D Roberts, Z Al-Kadhimi, I Bodo, E Winton, M Arellano, JF DiPersio	07/01/2018
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	RA Taplitz, EB Kennedy, EJ Bow, J Crews, C Gleason, DK Hawley, AA Langston, LJ Nastoupil, M Rajotte, K Rolston, L Strasfeld, CR Flowers	05/10/2018
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Hosoba, EK Waller, N Shenvi, M Graiser, KA Easley, Z Al-Kadhimi, A Andoh, AG Antun, S Barclay, CD Josephson, JL Koff, HJ Khoury, AA Langston, JC Zimring, JD Roback, CR Giver	05/01/2018
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. Leukemia & lymphoma	V Dhere, S Edelman, EK Waller, A Langston, M Graiser, EC Connolly, JM Switchenko, N Esiashvili, MK Khan	04/01/2018
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma. Cancer	RM Myers, BT Hill, BE Shaw, S Kim, HR Millard, M Battiwalla, NS Majhail, D Buchbinder, HM Lazarus, BN Savani, MED Flowers, A D'Souza, MJ Ehrhardt, A Langston, JA Yared, RJ Hayashi, A Daly, RF Olsson, Y Inamoto, AK Malone, Z DeFilipp, SP Margossian, AB Warwick, S Jaglowski, A Beitinjaneh, H Fung, KA Kasow, DI Marks, J Reynolds, K Stockerl-Goldstein, B Wirk, WA Wood, M Hamadani, P Satwani	02/15/2018
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematology reports	AP Jillella, ML Arellano, LT Heffner, M Gaddh, AA Langston, HJ Khoury, A Mangoankar, VK Kota	09/26/2017
Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention. Bone marrow transplantation	Z Al-Kadhimi, Z Gul, M Abidi, LG Lum, A Deol, W Chen, H Jang, C Ozust, A Langston, E Waller, J Uberti	09/01/2017
Opportunity for Collaboration Between Radiation Injury Treatment Network Centers and Medical Toxicology Specialists. Southern medical journal	E Davlantes, S Shartar, J Venero, A Steck, A Langston, ZN Kazzi	08/01/2017
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia? Cancer	JH Kong, EF Winton, LT Heffner, Z Chen, AA Langston, B Hill, M Arellano, F El-Rassi, A Kim, A Jillella, VK Kota, I Bodó, HJ Khoury	07/01/2017
Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma. Clinical lymphoma, myeloma & leukemia	AD Staton, AA Langston	07/01/2017
Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study. Infection control and hospital epidemiology	NN Shah, W McClellan, CR Flowers, S Lonial, H Khoury, EK Waller, A Langston, AK Nooka	06/01/2017
Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period. Transplant infectious disease : an official journal of the Transplantation Society	SD Aldrete, CS Kraft, MJ Magee, A Chan, D Hutcherson, AA Langston, BI Greenwell, EM Burd, R Friedman-Moraco	02/01/2017
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone marrow transplantation	Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller	01/01/2017
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia? Clinical lymphoma, myeloma & leukemia	Z DeFilipp, AA Langston, Z Chen, C Zhang, ML Arellano, F El Rassi, CR Flowers, VK Kota, Z Al-Kadhimi, R Veldman, AP Jillella, S Lonial, EK Waller, HJ Khoury	08/01/2016
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. The Journal of antimicrobial chemotherapy	OA Cornely, RF Duarte, S Haider, P Chandrasekar, D Helfgott, JL Jiménez, A Candoni, I Raad, M Laverdiere, A Langston, N Kartsonis, M Van Iersel, N Connelly, H Waskin	03/01/2016
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	JH Young, BR Logan, J Wu, JR Wingard, DJ Weisdorf, C Mudrick, K Knust, MM Horowitz, DL Confer, ER Dubberke, SA Pergam, FM Marty, LM Strasfeld, JWM Brown, AA Langston, MG Schuster, DR Kaul, SI Martin, C Anasetti	02/01/2016
Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital. Journal of stem cell research & therapy	HD Yun, T Dossul, L Bernal-Mizrachi, J Switchenko, C Ndibe, A Ibraheem, MD Dixon, AA Langston, AK Nooka, CR Flowers, RD Pentz, EK Waller	01/01/2016
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma. British journal of haematology	JB Cohen, JM Switchenko, JL Koff, R Sinha, JL Kaufman, HJ Khoury, N Bumpers, A Colbert, A Hutchison-Rzepka, LJ Nastoupil, LT Heffner, AA Langston, MJ Lechowicz, S Lonial, CR Flowers	11/01/2015
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Cancer	JE Vaughn, ML Sorror, BE Storer, TR Chauncey, MA Pulsipher, RT Maziarz, MB Maris, P Hari, GG Laport, GN Franke, ED Agura, AA Langston, AR Rezvani, R Storb, BM Sandmaier, DG Maloney	10/15/2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial. Transfusion	N Jagirdar, RD Harvey, A Nooka, C Flowers, J Kaufman, S Lonial, MJ Lechowicz, A Langston, C Lipscomb, C Gaylor, EK Waller	10/01/2015
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia	JB Cohen, S Bucur, EF Winton, R Sinha, LT Heffner, N King, S Lonial, AA Langston, EK Waller, A Hutchison-Rzepka, A Colbert, MJ Lechowicz, CR Flowers	09/01/2015
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood	Y Suessmuth, R Mukherjee, B Watkins, DT Koura, K Finstermeier, C Desmarais, L Stempora, JT Horan, A Langston, M Qayed, HJ Khoury, A Grizzle, JA Cheeseman, JA Conger, J Robertson, A Garrett, AD Kirk, EK Waller, BR Blazar, AK Mehta, HS Robins, LS Kean	06/18/2015
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma. Leukemia & lymphoma	LJ Nastoupil, PJ Shenoy, A Ambinder, JL Koff, AK Nooka, EK Waller, A Langston, M Seward, JL Kaufman, L Bernal-Mizrachi, N King, MJ Lechowicz, S Lonial, R Sinha, CR Flowers	02/01/2015
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema. Clinical lymphoma, myeloma & leukemia	SR Shams, DA Goldstein, JL Kaufman, J MacKelfresh, CR Flowers, AA Langston	12/01/2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia. Antimicrobial agents and chemotherapy	RF Duarte, J López-Jiménez, OA Cornely, M Laverdiere, D Helfgott, S Haider, P Chandrasekar, A Langston, J Perfect, L Ma, ML van Iersel, N Connelly, N Kartsonis, H Waskin	10/01/2014
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation. Haematologica	B Kornblit, DG Maloney, BE Storer, MB Maris, L Vindeløv, P Hari, AA Langston, MA Pulsipher, WA Bethge, TR Chauncey, T Lange, FB Petersen, K Hübel, AE Woolfrey, ME Flowers, R Storb, BM Sandmaier	10/01/2014
Incidence and geographic distribution of adult acute leukemia in the state of Georgia. Southern medical journal	F El Rassi, KC Ward, CR Flowers, LT Heffner, EK Waller, EF Winton, J Vaughn, BG Hill, A Langston, A Nooka, M Arellano, HJ Khoury	08/01/2014
Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma. Leukemia & lymphoma	Z Mitri, MT Siddiqui, F El Rassi, JT Holden, LT Heffner, A Langston, EK Waller, E Winton, M McLemore, L Bernal-Mizrachi, D Jaye, M Arellano, HJ Khoury	07/01/2014
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	AK Nooka, HR Johnson, JL Kaufman, CR Flowers, A Langston, C Steuer, M Graiser, Z Ali, NN Shah, S Rangaraju, D Nickleach, J Gao, S Lonial, EK Waller	06/01/2014
Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. International journal of radiation oncology, biology, physics	JL Mikell, EK Waller, JM Switchenko, S Rangaraju, Z Ali, M Graiser, WA Hall, AA Langston, N Esiashvili, HJ Khoury, MK Khan	06/01/2014
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series. Clinical lymphoma, myeloma & leukemia	AK Nooka, RD Harvey, A Langston, H Collins, S Lonial, JL Kaufman	04/01/2014
Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients. Leukemia	AK Nooka, JL Kaufman, S Muppidi, A Langston, LT Heffner, C Gleason, D Casbourne, D Saxe, LH Boise, S Lonial	03/01/2014
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors. Bone marrow transplantation	AA Langston, JM Prichard, S Muppidi, A Nooka, MJ Lechowicz, S Lonial, R Sinha, M Graiser, JL Kaufman, HJ Khoury, CR Flowers, EK Waller	02/01/2014
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials. Cancer	AK Nooka, JL Kaufman, M Behera, A Langston, EK Waller, CR Flowers, C Gleason, LH Boise, S Lonial	12/01/2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma. Clinical lymphoma, myeloma & leukemia	R Sinha, PJ Shenoy, N King, MJ Lechowicz, K Bumpers, D Hutcherson, M Arellano, A Langston, J Kaufman, LT Heffner, EK Waller, A Nooka, CR Flowers, S Lonial	12/01/2013
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	DT Koura, JT Horan, AA Langston, M Qayed, A Mehta, HJ Khoury, RD Harvey, Y Suessmuth, C Couture, J Carr, A Grizzle, HR Johnson, JA Cheeseman, JA Conger, J Robertson, L Stempora, BE Johnson, A Garrett, AD Kirk, CP Larsen, EK Waller, LS Kean	11/01/2013
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. Cancer	AG Antun, S Gleason, M Arellano, AA Langston, ML McLemore, M Gaddh, F el Rassi, L Bernal-Mizrachi, J Galipeau, LT Heffner, EF Winton, HJ Khoury	11/01/2013
Advances in hematopoietic stem cell transplantation in chronic myeloid leukemia. Discovery medicine	R Veldman, F El Rassi, S Holloway, A Langston, HJ Khoury	10/01/2013
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	RD Harvey, JL Kaufman, HR Johnson, A Nooka, L Vaughn, CR Flowers, HJ Khoury, MJ Lechowicz, AA Langston, S Lonial, EK Waller	09/01/2013
Inherited predisposition to multiple myeloma. Therapeutic advances in hematology	DT Koura, AA Langston	08/01/2013
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Lonial, M Akhtari, J Kaufman, C Torre, MJ Lechowicz, C Flowers, R Sinha, HJ Khoury, AA Langston, EK Waller	03/01/2013
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	CR Flowers, J Seidenfeld, EJ Bow, C Karten, C Gleason, DK Hawley, NM Kuderer, AA Langston, KA Marr, KV Rolston, SD Ramsey	02/20/2013
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Transfusion	JL Kaufman, CR Flowers, KD Rados, GB Calandra, JM Vose, LB Hewes, S Lonial, AA Langston, HJ Khoury, MJ Lechowicz, EK Waller	01/01/2013
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia. Cancer	M Arellano, S Pakkala, A Langston, M Tighiouart, L Pan, Z Chen, LT Heffner, S Lonial, E Winton, HJ Khoury	11/01/2012
A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias. Cancer	HJ Khoury, G Garcia-Manero, G Borthakur, T Kadia, MC Foudray, M Arellano, A Langston, B Bethelmie-Bryan, S Rush, K Litwiler, S Karan, H Simmons, AI Marcus, M Ptaszynski, H Kantarjian	07/15/2012
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years. Cancer	M Arellano, E Winton, L Pan, L Lima, M Tighiouart, K Bhalla, LT Heffner, J Neely, D Hutcherson, M McLemore, A Langston, HJ Khoury	01/15/2012
Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia. Clinical lymphoma, myeloma & leukemia	M Arellano, L Bernal-Mizrachi, L Pan, M Tighiouart, L Souza, X Guo, M McLemore, L Lima, S Sunay, LT Heffner, Z Chen, GZ Chen, A Langston, E Winton, HJ Khoury	10/01/2011
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion	J Li, E Hamilton, L Vaughn, M Graiser, H Renfroe, MJ Lechowicz, A Langston, JM Prichard, D Anderson, C Gleason, S Lonial, CR Flowers, JL Kaufman, EK Waller	10/01/2011
A cluster of mucormycosis infections in hematology patients: challenges in investigation and control of invasive mold infections in high-risk patient populations. Diagnostic microbiology and infectious disease	E Llata, DB Blossom, HJ Khoury, CY Rao, KA Wannemuehler, J Noble-Wang, AA Langston, BS Ribner, GM Lyon, KE Arnold, DR Jackson, ME Brandt, TM Chiller, SA Balajee, A Srinivasan, SS Magill	09/01/2011
Biomarkers of immune activation to screen for severe, acute GVHD. Bone marrow transplantation	KJ August, KY Chiang, RM Bostick, WD Flanders, EK Waller, A Langston, D Worthington-White, P Rowland, KF Moore, HJ Khoury, JT Horan	04/01/2011
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond. Cancer	L Lima, L Bernal-Mizrachi, D Saxe, KP Mann, M Tighiouart, M Arellano, L Heffner, M McLemore, A Langston, E Winton, HJ Khoury	03/15/2011
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion	M Akhtari, CR Giver, Z Ali, CR Flowers, CL Gleason, CD Hillyer, J Kaufman, HJ Khoury, AA Langston, MJ Lechowicz, S Lonial, HM Renfroe, JD Roback, M Tighiouart, L Vaughn, EK Waller	11/01/2010
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leukemia & lymphoma	H Tran, M Arellano, A Chamsuddin, C Flowers, LT Heffner, A Langston, MJ Lechowicz, A Tindol, E Waller, EF Winton, HJ Khoury	08/01/2010
Use of posaconazole in the treatment of invasive fungal infections. Expert review of hematology	AK Mehta, AA Langston	12/01/2009
Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies. Transplant infectious disease : an official journal of the Transplantation Society	S Murali, A Langston	12/01/2009
Detection of respiratory viruses with a multiplex polymerase chain reaction assay (MultiCode-PLx Respiratory Virus Panel) in patients with hematologic malignancies. Leukemia & lymphoma	S Murali, AA Langston, FS Nolte, G Banks, R Martin, AM Caliendo	04/01/2009
Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients. Bone marrow transplantation	M Akhtari, AA Langston, EK Waller, AA Gal	01/01/2009
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma. Bone marrow transplantation	S Murali, E Winton, EK Waller, LT Heffner, S Lonial, C Flowers, J Kaufman, M Arellano, MJ Lechowicz, KP Mann, HJ Khoury, AA Langston	10/01/2008
Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood	MS Hossain, JD Roback, BP Pollack, DL Jaye, A Langston, EK Waller	05/15/2007
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion	ML Hicks, S Lonial, A Langston, C Flowers, JD Roback, KJ Smith, S Mossavi Sai, D Teagarden, ES Hamilton, EK Waller, J Kaufman	04/01/2007
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma. Leukemia & lymphoma	S Lonial, M Arellano, D Hutcherson, A Langston, C Flowers, LT Heffner, E Winton, M Jo Lechowicz, EK Waller	10/01/2006
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma. Cancer	BT Brinker, EK Waller, T Leong, LT Heffner, I Redei, AA Langston, S Lonial	05/15/2006
A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Lonial, M Hicks, H Rosenthal, A Langston, I Redei, C Torre, M Duenzl, B Feinstein, J Cherry, EK Waller	12/01/2004
Update in acute leukemia 2003: a risk adapted approach to acute myeloblastic leukemia in adults. Seminars in oncology	EF Winton, AA Langston	04/01/2004
Update on myelodysplastic syndromes: new approaches to classification and therapy. Seminars in oncology	AA Langston, R Walling, EF Winton	04/01/2004
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults. Blood cells, molecules & diseases	EK Waller, CR Giver, H Rosenthal, J Somani, AA Langston, S Lonial, JD Roback, JM Li, MS Hossain, I Redei	01/01/2004
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	EK Waller, AA Langston, S Lonial, J Cherry, J Somani, AJ Allen, H Rosenthal, I Redei	07/01/2003
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood	AA Langston, I Redei, AM Caliendo, J Somani, D Hutcherson, S Lonial, S Bucur, J Cherry, A Allen, EK Waller	02/01/2002

Awards

Atlanta Magazine "Top Doctors," 2016-2020
James R. Eckman Award for Teaching Excellence, Winship Cancer Institute Fellowship Program, 2007
Alpha Omega Alpha, 1983
American Medical Women's Association Scholarship Achievement Citation, 1984
Lange Medical Publication Award

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

5	One star One star One star One star One star	Provider showed concern
5	One star One star One star One star One star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
5	One star One star One star One star One star	Provider included you in decisions
5	One star One star One star One star One star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	06/25/2026	I appreciate coming to see an MPN specialist here. I get such informed responses as compared to my regular hematologist oncologist at home.
One star One star One star One star One star	06/18/2026	Dr.Langston is excellent in every way. She allows and encourages me to live my life while battling cancer.
One star One star One star One star One star	05/27/2026	Dr. Langston has always explained things to me so that I can understand. She is wonderful.
One star One star One star One star One star	05/16/2026	Dr. Langston was very concerned about my condition and my care. She listened carefully and took immediate action on things that were over concerned to her.
One star One star One star One star One star	05/12/2026	Absolute excellence throughout the visit.
One star One star One star One star One star	04/24/2026	Dr. Langston is an exemplary physician, very knowledgeable and professional.
One star One star One star One star One star	04/03/2026	Dr. Langston is very patient with me. She listens well. Trust her completely.
One star One star One star One star One star	03/14/2026	Dr. Langston is excellent
One star One star One star One star One star	03/12/2026	Great care with Dr. Langston, ER response team and nurses and techs. Along with entire crew on the T899 ward.
One star One star One star One star One star	03/10/2026	Dr. Langston is an exceptional physician! She's not only professional, but she is genuinely caring and compassionate, as well as personable and encouraging.
One star One star One star One star One star	02/22/2026	Very clear explanations. Her confidence in the chosen regimen was confidence boosting to me.
One star One star One star One star One star	02/20/2026	Dr. Langston is patient and attentive.
One star One star One star One star One star	02/03/2026	Excellent
One star One star One star One star One star	01/27/2026	Dr. Langston seems made for her job. She is direct and comforting at the same time, and she instills great confidence in her intelligence and deep knowledge of her field.
One star One star One star One star One star	01/18/2026	Dr. Langston is the best Doctor; she is kind, knowledgeable, and compassionate!
One star One star One star One star One star	01/06/2026	My care provider is the greatest!
One star One star One star One star One star	01/06/2026	Did not really describe options. Just gave one procedure description.
One star One star One star One star One star	11/28/2025	More than just very good - I Would use the word excellent to answer these questions about Dr. Langston!
One star One star One star One star One star	11/22/2025	Excellent service from my Doctor
One star One star One star One star One star	09/30/2025	Dr Langston Is very clear and plain spoken with her explantations. I never feel rushed.
One star One star One star One star One star	09/16/2025	Dr. Langston is engaged and concerned with my care, balancing a great deal of uncertainty and insurance push-back with how best to guard my health and move forward with possible treatment
One star One star One star One star One star	08/28/2025	Very good experience
One star One star One star One star One star	08/26/2025	Dr Langston is the best
One star One star One star One star One star	08/16/2025	Dr. Langston is very knowledgeable and is sincere.
One star One star One star One star One star	08/12/2025	Dr. Langston was thorough and counseled my entire family.
One star One star One star One star One star	07/10/2025	No complaints. All issues fully and clearly explained and all questions answered. I never felt rushed or unimportant in my entire time.
One star One star One star One star One star	07/09/2025	Great experience/outcome.Thank you!
One star One star One star One star One star	07/01/2025	Explain results and procedures and have ability to ask questions and show concerns about how you are doing.
One star One star One star One star One star	06/25/2025	Dr Langston has always been a square shooter with me. Honest truthful answers that lets me know what I need to do and what she and treatment will do. Always makes me feel like and adult and never belittles me or others. Have learned so much about my condition and what will work for me and if not how to bring it up and we can adapt.
One star One star One star One star One star	05/23/2025	Very attentive.
One star One star One star One star One star	05/22/2025	Dr. Langston is excellent. I would and have recommended her to others.
One star One star One star One star One star	05/20/2025	Excellent experience.
One star One star One star One star One star	05/17/2025	Dr. Langston always listens to me and my concerns. She is the best at what she does.
One star One star One star One star One star	04/16/2025	I like how the process was explained.
One star One star One star One star One star	04/08/2025	Dr. Langston is excellent!
One star One star One star One star One star	04/08/2025	Dr Langston has always been compassionate and throughly explained treatment plan and possible outcomes.
One star One star One star One star One star	03/27/2025	Dr Langston discussed the good and bad concerns! Much appreciated!
One star One star One star One star One star	03/22/2025	We would recommend Dr. Langston without hesitation. She is an extraordinary physician who loves what she does and care for her patients.
One star One star One star One star One star	02/18/2025	Dr. Langston always listens to everything I say and explains everything very thoroughly. She is wonderful!!!
One star One star One star One star One star	02/11/2025	Dr.Langston and her team are awesome
One star One star One star One star One star	02/04/2025	I was extremely happy with everyone I had contact with. Dr. Langston and her staff were very good at explaining my choices for my next medical decision.
One star One star One star One star One star	02/01/2025	Dr Langston is top notch. I only have praise for her
One star One star One star One star One star	01/30/2025	They listened and included me in the decisions being made about my plan of care.
One star One star One star One star One star	01/08/2025	Dr. Langston helped me understand my recent prostate cancer metastasis diagnosis even though this is not her specialty. I have been under her care for years for NHL and have a tremendous amount of respect and trust in her expertise. Further more she helped my wife and I understand the recommended treatments, and advised us what is important to do. Dr. Langston, approached the situation very calmly and educated my wife and I on test results and treatments. This gave us a tremendous amount of peace of mind which goes a long way with a cancer diagnosis. We would not hesitate to call her again and another situation like this. She is invaluable Member of my care team!
One star One star One star One star One star	12/17/2024	She was very educated
One star One star One star One star One star	12/17/2024	We collaborated on treatments and medications. She listened to my concerns. I was a true partner in my care.
One star One star One star One star One star	12/06/2024	Dr Tarun and Dr. Langston answered all of my questions, addressed my fears, I felt at ease regarding my disease, treatment and future care after this clinical encounter.
One star One star One star One star One star	12/03/2024	Dr Langston was very thorough and carefully explained options and answered our questions. A++
One star One star One star One star One star	11/19/2024	Good experience
One star One star One star One star One star	11/13/2024	Dr. Langston was excellent.
One star One star One star One star One star	11/08/2024	I feel Dr. Langston and her team are excellent. They promptly answered all of my questions and concerns.
One star One star One star One star One star	11/07/2024	They are all kind and sweet.
One star One star One star One star One star	09/25/2024	Dr. Langston is extremely thorough in her explanations and inclusion of family in her care of her patients. As a physician, she is exceptional. Yes, I would recommend her.
One star One star One star One star One star	08/01/2024	Dr Langston was not rushed. We had a very good conversation and she fully considered my concerns when recommending treatment
One star One star One star One star One star	07/28/2024	Very good experience